Orion Portfolio Solutions’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
AT
JSAM
MIM
AWC
QC
Orion Portfolio Solutions's PPH Position: Q1 2025 in Review
Orion Portfolio Solutions increased its VanEck Pharmaceutical ETF (PPH) stake by 19% in Q1 2025, buying an estimated $505K and bringing the position to 35,490 shares worth $3.23M. The position accounts for 0.03% of the portfolio, ranked #496.
Orion Portfolio Solutions first reported a position in PPH in Q4 2019 and has held it in 22 quarters since. The position peaked at $11M in Q4 2019. 136 funds tracked by Wall St. Rank hold PPH as of Q1 2025.
- Orion Portfolio Solutions held 35,490 shares of VanEck Pharmaceutical ETF worth $3.23M as of Q1 2025.
- Orion Portfolio Solutions bought 5,610 VanEck Pharmaceutical ETF shares in Q1 2025, an estimated $505K.
- VanEck Pharmaceutical ETF made up 0.03% of Orion Portfolio Solutions's portfolio in Q1 2025, its #496 holding.
- Orion Portfolio Solutions first reported a position in VanEck Pharmaceutical ETF in Q4 2019 and has held it in 22 quarters since.
- Orion Portfolio Solutions's VanEck Pharmaceutical ETF position peaked at $11M in Q4 2019.
- 136 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2025.
Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.